Changes in Beliefs About Post-Transplant Immunosuppressants Over Time and Its Relation to Medication Adherence and Kidney Graft Dysfunction: A Follow-Up Study

References

• Neuberger JM, Bechstein WO, Kuypers DR, et al. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: a Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group. Transplantation. 2017;101(4SSuppl 2):S1–S56.
   Web of Science ®Google Scholar
• Data of the WHO-ONT. Global Observatory on Donation and Transplantation; WHO-ONT collaboration; 2016. Available from: http://www.transplant-observatory.org/data-charts-and-tables/chart/. Accessed September 6, 2021.
   Google Scholar
• Data of the Coordination Center for Transplantation. Prague; 2019.  Available from: https://kst.cz/en/. Accessed September 6, 2021.
   Google Scholar
• Purnajo I, Beaumont JL, Polinsky M, Alemao E, Everly MJ. Trajectories of health-related quality of life among renal transplant patients associated with graft failure and symptom distress: analysis of the BENEFIT and BENEFIT-EXT trials. Am J Transplant. 2020;20(6):1650–1658.
   PubMed Web of Science ®Google Scholar
• Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.
   PubMed Web of Science ®Google Scholar
• De Geest S, Burkhalter H, Bogert L, et al. Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss Transplant Cohort Study. Transpl Int. 2014;27(7):657–666.
   Web of Science ®Google Scholar
• Couzi L, Moulin B, Morin MP, et al. Factors predictive of medication nonadherence after renal transplantation: a French observational study. Transplantation. 2013;95(2):326–332.
   Web of Science ®Google Scholar
• De Geest S, Burkhalter H, Bogert L, Berben L, Glass TR, Denhaerynck K; Psychosocial Interest Group; Swiss Transplant Cohort Study. Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss Transplant Cohort Study. Transpl Int. 2014;27(7):657–666.
   Web of Science ®Google Scholar
• Villeneuve C, Rousseau A, Rerolle JP, et al. Adherence profiles in kidney transplant patients: causes and consequences. Patient Educ Couns. 2020;103(1):189–198.
   Web of Science ®Google Scholar
• Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1–24.
   Web of Science ®Google Scholar
• Griva K, Davenport A, Harrison M, et al. Non-adherence to immunosuppressive medications in kidney transplantation: intent vs. forgetfulness and clinical markers of medication intake. Ann Behav Med. 2012;44(1):85–93.
   PubMed Web of Science ®Google Scholar
• Chisholm-Burns M, Pinsky B, Parker G, et al. Factors related to immunosuppressant medication adherence in renal transplant recipients. Clin Transplant. 2012;26:706–713.
   Web of Science ®Google Scholar
• Horne R, Chapman SC, Parham R, et al. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013;8(12):e80633.
   PubMed Web of Science ®Google Scholar
• Vankova B, Mala-Ladova K, Kubena AA, et al. Immunosuppressive therapy related adherence, beliefs and self-management in kidney transplant outpatients. Patient Prefer Adherence. 2018;12:2605–2613.
   Web of Science ®Google Scholar
• Horne R, Cooper V, Wileman V, et al. Supporting adherence to medicines for long-term conditions: a perceptions and practicalities approach based on an extended common-sense model. Eur Psychol. 2019;24(1):82–96.
   Web of Science ®Google Scholar
• Butler JA, Roderick P, Mullee M, et al. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation. 2004;77(5):769–776.
   PubMed Web of Science ®Google Scholar
• Duncan S, Annunziato RA, Dunphy C, et al. A systematic review of immunosuppressant adherence interventions in transplant recipients: decoding the streetlight effect. Pediatr Transplant. 2018;22(1). doi:10.1111/petr.13086
   Web of Science ®Google Scholar
• Vrijens B, Antoniou S, Burnier M, et al. Current situation of medication adherence in hypertension. Front Pharmacol. 2017;8:100.
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002;17(1):17–32.
   Web of Science ®Google Scholar
• Matoulkova P, Krulichova IS, Macek K, et al. Chronically ill Czech patients’ beliefs about medicines: the psychometric properties and factor structure of the BMQ-CZ. Ther Innov Regul Sci. 2013;47(3):341–348.
   Web of Science ®Google Scholar
• Ladova K, Matoulkova P, Zadak Z, et al. Self-reported adherence by Mars-CZ reflects LDL cholesterol goal achievement among statin users: validation study in the Czech Republic. J Eval Clin Pract. 2014;20(5):671–677.
   Web of Science ®Google Scholar
• Dobbels F, Berben L, De Geest S, et al. The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review. Transplantation. 2010;90(2):205–219.
   PubMed Web of Science ®Google Scholar
• Chater AM, Parham R, Riley S, Hutchison AJ, Horne R. Profiling patient attitudes to phosphate binding medication: a route to personalising treatment and adherence support. Psychol Health. 2014;29(12):1407–1420.
   PubMed Web of Science ®Google Scholar
• Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for Patient-Reported Outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8(2):94–104.
   PubMed Web of Science ®Google Scholar
• Massey EK, Tielen M, Laging M, et al. Discrepancies between beliefs and behavior: a prospective study into immunosuppressive medication adherence after kidney transplantation. Transplantation. 2015;99(2):375–380.
   PubMed Web of Science ®Google Scholar
• Bünemann M, Bauer-Hohmann M, Klewitz F, et al. Beliefs about immunosuppressant medication and correlates in a German kidney transplant population. J Psychosom Res. 2020;132:109989.
   Web of Science ®Google Scholar
• Denhaerynck K, Berben L; BRIGHT study team, et al. Multilevel factors are associated with immunosuppressant nonadherence in heart transplant recipients: the international BRIGHT study. Am J Transplant. 2018;18(6):1447–1460.
   Web of Science ®Google Scholar
• Marsicano-Souza EO, Colugnati F, Geest S, Sanders-Pinheiro H. Nonadherence to immunosuppressives and treatment in kidney transplant: ADHERE Brazil Study. Rev Saude Publica. 2021;55:33.
   Web of Science ®Google Scholar
• Gokoel SRM, Gombert-Handoko KB, Zwart TC, et al. Medication non-adherence after kidney transplantation: a critical appraisal and systematic review. Transplant Rev. 2020;34(1):100511.
   Web of Science ®Google Scholar
• De geest S, Zullig LL, Dunbar-Jacob J, et al. ESPACOMP medication adherence reporting guideline (EMERGE). Ann Intern Med. 2018;169(1):30–35.
   PubMed Web of Science ®Google Scholar
• Massey EK, Tielen M, Laging M, et al. The role of goal cognitions, illness perceptions and treatment beliefs in self-reported adherence after kidney transplantation: a cohort study. J Psychosom Res. 2013;75(3):229–234.
   PubMed Web of Science ®Google Scholar
• Unni E, Shiyanbola OO, Farris KB. Change in medication adherence and beliefs in medicines over time in older adults. Glob J Health Sci. 2015;8(5):39–47.
   Google Scholar
• Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;2014(11):CD000011.
   PubMedGoogle Scholar
• Takemoto S, Pinsky B, Schnitzler M, et al. A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients. Am J Transplant. 2007;7(12):2704–2711.
   PubMed Web of Science ®Google Scholar
• Michelon T, Piovesan F, Garcia V, et al. Noncompliance as a cause of renal graft loss. Transplant Proc. 2002;34(7):2768–2770.
   Web of Science ®Google Scholar
• Gaynor JJ, Ciancio G, Guerra G, et al. Graft failure due to noncompliance among 628 kidney transplant recipients with long-term follow-up: a single-center observational study. Transplantation. 2014;97(9):925–933.
   Web of Science ®Google Scholar
• Kostalova B, Ribaut J, Dobbels F, et al. Medication adherence interventions in transplantation lack information on how to implement findings from randomized controlled trials in real-world settings: a systematic review. Transplant Rev. 2022;36(1):100671.
   Web of Science ®Google Scholar
• Zullig LL, Deschodt M, Liska J, et al. Moving from the trial to the real world: improving medication adherence using insights of implementation science. Annu Rev Pharmacol Toxicol. 2019;59:423–445.
   Web of Science ®Google Scholar